Anti-Necroptotic Effects of Itaconate and its Derivatives
Authors:
- 27 September 2023
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 47 (1) , 285-306
Abstract
Itaconate is an unsaturated dicarboxylic acid that is derived from the decarboxylation of the Krebs cycle intermediate cis-aconitate and has been shown to exhibit anti-inflammatory and anti-bacterial/viral properties. But the mechanisms underlying itaconate’s anti-inflammatory activities are not fully understood. Necroptosis, a lytic form of regulated cell death (RCD), is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like protein (MLKL) signaling. It has been involved in the pathogenesis of organ injury in many inflammatory diseases. In this study, we aimed to explore whether itaconate and its derivatives can inhibit necroptosis in murine macrophages, a mouse MPC-5 cell line and a human HT-29 cell line in response to different necroptotic activators. Our results showed that itaconate and its derivatives dose-dependently inhibited necroptosis, among which dimethyl itaconate (DMI) was the most effective one. Mechanistically, itaconate and its derivatives inhibited necroptosis by suppressing the RIPK1/RIPK3/MLKL signaling and the oligomerization of MLKL. Furthermore, DMI promoted the nuclear translocation of Nrf2 that is a critical regulator of intracellular redox homeostasis, and reduced the levels of intracellular reactive oxygen species (ROS) and mitochondrial superoxide (mtROS) that were induced by necroptotic activators. Consistently, DMI prevented the loss of mitochondrial membrane potential induced by the necroptotic activators. In addition, DMI mitigated caerulein-induced acute pancreatitis in mice accompanied by reduced activation of the necroptotic signaling in vivo. Collectively, our study demonstrates that itaconate and its derivatives can inhibit necroptosis by suppressing the RIPK1/RIPK3/MLKL signaling, highlighting their potential applications for treating necroptosis-associated diseases.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (21622318)
- National Natural Science Foundation of China (81773965, 81873064)
- Guangzhou Basic and Applied Basic Foundation (202201010725)
This publication has 71 references indexed in Scilit:
- Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosisCell Research, 2013
- Succinate dehydrogenase: the complex roles of a simple enzymeCurrent Opinion in Plant Biology, 2013
- Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid productionProceedings of the National Academy of Sciences, 2013
- Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosisProceedings of the National Academy of Sciences, 2012
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Molecular mechanisms of necroptosis: an ordered cellular explosionNature Reviews Molecular Cell Biology, 2010
- Identification of RIP1 kinase as a specific cellular target of necrostatinsNature Chemical Biology, 2008
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injuryNature Chemical Biology, 2005
- Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase PhosphatasesCell, 2005
- Tumor Necrosis Factor-induced Nonapoptotic Cell Death Requires Receptor-interacting Protein-mediated Cellular Reactive Oxygen Species AccumulationJournal of Biological Chemistry, 2004